How big is the Global Digital Genome Market?

The Global Digital Genome Market size is expected to reach USD 30.68 billion in 2024 and grow at a CAGR of 13.46% to reach USD 57.68 billion by 2029. Read More

What is the current Global Digital Genome Market size?

In 2024, the Global Digital Genome Market size is expected to reach USD 30.68 billion. Read More

Who are the key players in Global Digital Genome Market?

bioMérieux , Agilent Technologies, Inscripta, Inc., GE Healthcare and Invitae Corporation are the major companies operating in the Global Digital Genome Market. Read More

Which is the fastest growing region in Global Digital Genome Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Digital Genome Market?

In 2024, the North America accounts for the largest market share in Global Digital Genome Market. Read More

What years does this Global Digital Genome Market cover, and what was the market size in 2023?

In 2023, the Global Digital Genome Market size was estimated at USD 27.04 billion. The report covers the Global Digital Genome Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Digital Genome Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Global Digital Genome Market Share

Statistics for the 2023 & 2024 Global Digital Genome market share, created by Mordor Intelligence™ Industry Reports. Global Digital Genome share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Global Digital Genome Industry

The digital genome market is competitive with the presence of several global and international market players. The key players are adopting different growth strategies to enhance their market presence, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions. Some of the key players in the market are bioMérieux, Agilent Technologies, Inscripta, Inc., GE Healthcare, and Invitae Corporation.